7-55157447-G-C

Variant summary

Our verdict is Benign. The variant received -14 ACMG points: 0P and 14B. BP4_StrongBP6_ModerateBA1

The NM_005228.5(EGFR):​c.1208-216G>C variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.306 in 152,236 control chromosomes in the GnomAD database, including 7,474 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★).

Frequency

Genomes: 𝑓 0.31 ( 7474 hom., cov: 33)

Consequence

EGFR
NM_005228.5 intron

Scores

2

Clinical Significance

Benign criteria provided, single submitter B:1

Conservation

PhyloP100: -2.18

Publications

10 publications found
Variant links:
Genes affected
EGFR (HGNC:3236): (epidermal growth factor receptor) The protein encoded by this gene is a transmembrane glycoprotein that is a member of the protein kinase superfamily. This protein is a receptor for members of the epidermal growth factor family. EGFR is a cell surface protein that binds to epidermal growth factor, thus inducing receptor dimerization and tyrosine autophosphorylation leading to cell proliferation. Mutations in this gene are associated with lung cancer. EGFR is a component of the cytokine storm which contributes to a severe form of Coronavirus Disease 2019 (COVID-19) resulting from infection with severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2). [provided by RefSeq, Jul 2020]
EGFR Gene-Disease associations (from GenCC):
  • lung cancer
    Inheritance: AD Classification: DEFINITIVE Submitted by: G2P, Ambry Genetics
  • non-small cell lung carcinoma
    Inheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
  • inflammatory skin and bowel disease, neonatal, 2
    Inheritance: AR Classification: STRONG, MODERATE, LIMITED Submitted by: Genomics England PanelApp, Labcorp Genetics (formerly Invitae), Ambry Genetics, G2P
  • neonatal inflammatory skin and bowel disease
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -14 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.89).
BP6
Variant 7-55157447-G-C is Benign according to our data. Variant chr7-55157447-G-C is described in ClinVar as Benign. ClinVar VariationId is 1246809.Status of the report is criteria_provided_single_submitter, 1 stars.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.358 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
EGFRNM_005228.5 linkc.1208-216G>C intron_variant Intron 10 of 27 ENST00000275493.7 NP_005219.2 P00533-1Q504U8F2YGG7

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
EGFRENST00000275493.7 linkc.1208-216G>C intron_variant Intron 10 of 27 1 NM_005228.5 ENSP00000275493.2 P00533-1

Frequencies

GnomAD3 genomes
AF:
0.306
AC:
46541
AN:
152118
Hom.:
7482
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.265
Gnomad AMI
AF:
0.385
Gnomad AMR
AF:
0.286
Gnomad ASJ
AF:
0.307
Gnomad EAS
AF:
0.112
Gnomad SAS
AF:
0.192
Gnomad FIN
AF:
0.269
Gnomad MID
AF:
0.361
Gnomad NFE
AF:
0.361
Gnomad OTH
AF:
0.337
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.306
AC:
46545
AN:
152236
Hom.:
7474
Cov.:
33
AF XY:
0.297
AC XY:
22100
AN XY:
74438
show subpopulations
African (AFR)
AF:
0.265
AC:
11021
AN:
41518
American (AMR)
AF:
0.285
AC:
4369
AN:
15312
Ashkenazi Jewish (ASJ)
AF:
0.307
AC:
1065
AN:
3472
East Asian (EAS)
AF:
0.111
AC:
577
AN:
5180
South Asian (SAS)
AF:
0.191
AC:
922
AN:
4826
European-Finnish (FIN)
AF:
0.269
AC:
2855
AN:
10608
Middle Eastern (MID)
AF:
0.350
AC:
103
AN:
294
European-Non Finnish (NFE)
AF:
0.361
AC:
24579
AN:
68002
Other (OTH)
AF:
0.333
AC:
703
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.494
Heterozygous variant carriers
0
1627
3253
4880
6506
8133
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
462
924
1386
1848
2310
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.208
Hom.:
446
Bravo
AF:
0.305
Asia WGS
AF:
0.168
AC:
586
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not provided Benign:1
Jan 10, 2019
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.89
CADD
Benign
0.23
DANN
Benign
0.42
PhyloP100
-2.2
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs13222549; hg19: chr7-55225140; API